Press release
Liver Fibrosis Market to Reach USD 4.86 Billion by 2034
Liver Fibrosis Market Size
In 2024, the liver fibrosis market was valued at USD 2,317.70 million, fueled by a rise in chronic liver conditions such as nonalcoholic steatohepatitis (NASH), hepatitis C, and alcohol-related liver disease. Growing public health awareness and improved screening protocols have significantly contributed to early detection.
Looking ahead, the market is projected to expand at a CAGR of 7.70% from 2025 to 2034, reaching approximately USD 4,866.47 million by 2034. The increasing burden of lifestyle-related diseases and an aging population are key contributors to this anticipated growth.
Get a Free Sample Report with Table of Contents - https://bitl.to/4iLJ.
Liver Fibrosis Market Share
North America, particularly the United States, currently holds a dominant share in the global liver fibrosis market, driven by strong research infrastructure, high awareness, and availability of advanced diagnostics. The 7MM regions-including the U.S., U.K., Germany, France, Italy, Spain, and Japan-together account for a significant portion of the market, thanks to increased healthcare expenditure and clinical trial activity.
In terms of condition-specific share, nonalcoholic steatohepatitis (NASH) is gaining momentum due to its growing prevalence in populations affected by obesity and metabolic syndrome. Meanwhile, chronic liver disease and hepatitis C remain primary contributors to disease burden and market opportunity.
Liver Fibrosis Market Growth & Trends
Several key trends are shaping the future of the liver fibrosis market:
Rise in NASH Cases: As obesity and type 2 diabetes cases surge globally, NASH-related liver fibrosis is becoming a leading concern. Pharmaceutical companies are investing heavily in novel therapeutic options targeting NASH progression.
Technological Advancements: Imaging technologies like elastography and fibro-scans are enabling non-invasive liver fibrosis assessment, reducing the dependency on biopsies.
Personalized Medicine: The development of biomarker-based therapies and gene-specific interventions is transforming treatment pathways and improving clinical outcomes.
Regulatory Support: Fast-track designations from regulatory agencies are accelerating the development of new liver fibrosis therapies.
For readers seeking a broader understanding of liver fibrosis as a medical condition, the Wikipedia page on liver fibrosis offers a helpful overview of the disease's causes and progression.
Read the Full Report with the Table of Contents - https://bitl.to/4iLH.
Liver Fibrosis Market Case Studies & News
Recent developments across the industry underscore the dynamic nature of this market:
FibroGen, Inc. has been at the forefront with its research into anti-fibrotic therapies targeting pro-fibrotic signaling pathways.
Gilead Sciences and Intercept Pharmaceuticals have invested in NASH-focused pipeline candidates aimed at halting or reversing liver scarring.
Johnson & Johnson and Merck & Co. are exploring combination therapies that integrate fibrosis-reducing agents with anti-inflammatory drugs.
Pharmaxis has advanced clinical trials for lysyl oxidase inhibitors (LOX) that show promise in fibrosis treatment.
Liver Fibrosis Market Analysis
Competitive Landscape:
The liver fibrosis market is marked by intense R&D activity, especially in the area of antifibrotic drugs. Major pharmaceutical firms are either developing proprietary molecules or forming strategic alliances to strengthen their pipelines.
Regional Insights:
The United States leads in clinical trials, investment, and adoption of advanced diagnostics.
Japan: With its aging population and high healthcare standards, it's a significant market for fibrosis detection and care.
Europe: Countries like Germany and France are progressing through well-structured public health programs focused on liver health and preventive care.
Regulatory Dynamics:
Agencies like the U.S. FDA and EMA are increasingly offering accelerated approval paths and orphan drug designations to encourage innovation in fibrosis therapeutics. This is encouraging smaller biotech firms to enter the market with targeted solutions.
Liver Fibrosis Market Segmentation
By Condition:
Chronic Liver Diseases
Hepatitis C
Nonalcoholic Steatohepatitis (NASH)
By Treatment Type:
Peroxisome Proliferator-Activated Receptors (PPAR)-alpha Agonist
ACE Inhibitors
Hepatotropic Drugs
Others
By Distribution Channel:
Hospital Pharmacies
Retail Stores and Pharmacies
Online Providers
By End User:
Hospitals
Clinics
Others
By Region (7MM):
United States
United Kingdom
Germany
France
Italy
Spain
Japan
Liver Fibrosis Market Key Players
Several leading pharmaceutical and biotechnology companies are shaping the liver fibrosis landscape:
F. Hoffmann-La Roche
Mylan N.V.
Sanofi
GlaxoSmithKline plc
AstraZeneca
Johnson & Johnson
Merck & Co.
Bristol-Myers Squibb
Vertex Pharmaceuticals
FibroGen, Inc.
Pharmaxis
Dicerna Pharmaceuticals, Inc.
Dynavax Technologies
These players are involved in diverse initiatives ranging from molecular research to clinical trial collaborations and market expansion strategies.
Uncover More Reports
Genomics Market - https://bitl.to/4eQQ
Legal Marijuana Market - https://bitl.to/4IdS
United States Medical Adhesives Market - https://linkd.so/3CsB
Ataxia Market - https://linkd.so/3CsC
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Fibrosis Market to Reach USD 4.86 Billion by 2034 here
News-ID: 4072086 • Views: …
More Releases from Expert Market Research
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and…
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions.
The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering…
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy.
Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial…
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview
The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the…
More Releases for Liver
Acute on Chronic Liver Failure Market Impacts Liver Disease Patients By 2031
Global Acute On Chronic Liver Failure Market reached at a CAGR during the forecast period 2024-2031.
Acute On Chronic Liver Failure Market, as detailed in the DataM Intelligence report, presents a strategic overview of the industry backed by in-depth data and market trends. The study highlights the performance and positioning of major players, focusing on their offerings, pricing models, financial outcomes, and growth strategies. It serves as a concise yet insightful…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
